Concepedia

Kerrie Clarke

KC

9

Publications

761

Citations

9

H-Index

1996

Active since

Affiliations

Ludwig Cancer Research(Current)

Albury Wodonga Health

UNSW Sydney

Austin Health

Walter and Eliza Hall Institute of Medical Research

Kerrie Clarke is an author at Ludwig Cancer Research specializing in medicine, oncology, and immunology.

Top concepts

Publications per year

1996–2022

9

Publications

9

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

Russell L. Basser, John E.J. Rasko, Kerrie Clarke et al. · The Lancet · 1996 · 216 citations

, , +8

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

Russell L. Basser, John E.J. Rasko, Kerrie Clarke et al. · PubMed · 1997 · 201 citations

Plasma Epstein-Barr Virus (EBV) DNA Is a Biomarker for EBV-Positive Hodgkin's Lymphoma

Maher K. Gandhi, Eleanore Lambley, Jacqueline M. Burrows et al. · Clinical Cancer Research · 2006 · 137 citations

Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG‐rHuMGDF

John E.J. Rasko, Russell L. Basser, Jan Boyd et al. · British Journal of Haematology · 1997 · 64 citations · Full text

In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.

Kerrie Clarke, Fook-Thean Lee, Martin W. Brechbiel et al. · PubMed · 2000 · 50 citations

, , +20

Rows per page

1–5 of 9